Evidence map›Paper›PMID 29887245›Full record

ReviewMolecular metabolism2018

Sexual dimorphism of cardiometabolic dysfunction: Gut microbiome in the play?

Tzu-Wen L Cross, Kazuyuki Kasahara, Federico E Rey

Open access · goldAbstract readReview
In one paragraph

Review in Molecular metabolism, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 2 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 2 syntheses or guidelines pooled it, 90 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Food science & nutrition · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Hepatic immune regulation and sex disparities.Nature reviews. Gastroenterology & hepatology · 2024
    Review
  12. Observational
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Tzu-Wen L CrossCardiovascular Research Center, University of Wisconsin-Madison, Madison, WI, 53705, United States; Department of Bacteriology, University of Wisconsin-Madison, Madison, WI, 53706, United States. Electronic address: tlcross@wisc.edu.
Kazuyuki KasaharaDepartment of Bacteriology, University of Wisconsin-Madison, Madison, WI, 53706, United States. Electronic address: kasahara2@wisc.edu.
Federico E ReyCardiovascular Research Center, University of Wisconsin-Madison, Madison, WI, 53705, United States; Department of Bacteriology, University of Wisconsin-Madison, Madison, WI, 53706, United States. Electronic address: ferey@wisc.edu.
University of Wisconsin–Madison · US

Funding

Training Program in Translational Cardiovascular Science (TPTCS)T32HL007936 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI Lee Lochbaum Eckhardt, Gail A Robertson · 2001 to 2026
$11.6M
Collaborative Cross of the Microbiome and Metabolic DiseaseR01DK108259 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI REY, FEDERICO E · 2015 to 2019
$2.1M
NHLBI NIH HHS T32 HL007936NIDDK NIH HHS R01 DK108259
6 · The paper itself

Abstract

backgroundSex is one of the most powerful modifiers of disease development. Clear sexual dimorphism exists in cardiometabolic health susceptibility, likely due to differences in sex steroid hormones. Changes in the gut microbiome have been linked with the development of obesity, type 2 diabetes, and atherosclerosis; however, the impact of microbes in sex-biased cardiometabolic disorders remains unclear. The gut microbiome is critical for maintaining a normal estrous cycle, testosterone levels, and reproductive function. Gut microbes modulate the enterohepatic recirculation of estrogens and androgens, affecting local and systemic levels of sex steroid hormones. Gut bacteria can also generate androgens from glucocorticoids. SCOPE OF REVIEW: This review summarizes current knowledge of the complex interplay between sexual dimorphism in cardiometabolic disease and the gut microbiome. MAJOR

conclusionsEmerging evidence suggests the role of gut microbiome as a modifier of disease susceptibility due to sex; however, the impact on cardiometabolic disease in this complex interplay is lacking. Elucidating the role of gut microbiome on sex-biased susceptibility in cardiometabolic disease is of high relevance to public health given its high prevalence and significant financial burden.

Indexed as

Gastrointestinal MicrobiomeSex CharacteristicsAnimalsCardiovascular DiseasesGonadal Steroid HormonesHumansMetabolic SyndromeMyocardiumGonadal Steroid HormonesCardiovascular diseaseGut microbiotaMetabolic diseaseSex differencesSteroids

Identifiers

PMID29887245
PMCPMC6066746
OpenAlexW2805303935

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.